Bioisosterism

Part of speech: noun

Definitions

1. The concept involving replacement of atoms or groups within a molecule by others with similar physical or chemical properties to create compounds with comparable biological effects; a strategy used to modify drug molecules to improve efficacy or reduce side effects; an approach in medicinal chemistry aimed at optimizing molecular interactions with biological targets
2. A technique where parts of a molecular structure are substituted by biologically equivalent atoms or groups to produce analogs retaining similar activity; a method employed to develop new pharmaceuticals by mimicking structural features; a principle guiding the design of molecules with preserved biological function but altered chemical characteristics
3. The practice of exchanging molecular fragments with chemically or functionally similar ones to achieve parallel biological properties; an approach to drug design that alters molecular components to influence pharmacokinetics or binding; a strategy focused on maintaining biological activity while modifying molecular structure to improve therapeutic profiles

Etymology: The concept behind this term emerged from the fields of chemistry and pharmacology, particularly in the mid-20th century, when scientists sought ways to modify molecules to retain biological activity while improving properties like stability, toxicity, or solubility. It draws on the idea of "isosteres," which were originally understood as atoms or groups with similar sizes and electronic configurations that could replace each other in chemical compounds without drastically altering the compound’s shape or function. The prefix comes from "bio-" meaning life or biological, indicating that this term specifically pertains to biological systems. "Isosterism" itself derives from the Greek roots "iso-" meaning equal or same, and "stereos" meaning solid or three-dimensional form. Isosteres were first systematically studied by Irving Langmuir, a Nobel laureate in chemistry, in the early 20th century, who defined them as molecules or ions with the same number of atoms and valence electrons, leading to similar physical or chemical properties. In the context of drug design, bioisosterism refers to replacing one part of a molecule with another that has similar biological properties, aiming to maintain or enhance the desired biological effect while potentially reducing side effects or improving pharmacokinetics. This practice became a fundamental tool in medicinal chemistry during the 1950s and 1960s, as researchers realized that subtle changes to molecular structure could have profound effects on a drug's interaction with biological targets. The suffix "-ism" here marks the concept or practice of using such replacements. Thus, the term encapsulates both the theoretical idea and its practical application in biology and medicine. It is a compound of bio- + isosterism, where the latter came from earlier chemical terminology but acquired a new dimension when applied to living systems, highlighting the interdisciplinary nature of modern scientific language.

Synonyms: bioisostery, bioisosteric replacement